Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0000905148-21-000282

Chief Business Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Korbel Gregory Alan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-10 Grant or award : show line 1 in the form +15,000 25,500 D
Loading xslF345X03/form4.xml…